Ranbaxy Laboratories Mergers and Acquisitions Summary

Life ScienceCompany

Ranbaxy Laboratories has acquired 2 companies of its own. A total of 1 acquisition came from private equity firms.

Ranbaxy Laboratories’ largest acquisition to date was in 2006, when it acquired Terapia SA for $324M. Ranbaxy Laboratories has acquired in 2 countries. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Ranbaxy Laboratories’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Ranbaxy Laboratories Ltd.

Devika Tower 12th Floor 6, Nehru Place,
New Delhi, 110019
India,
91 11 2623 7508
www.ranbaxy.com

Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # 2 - - - - - 2
vol $324M $324M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Zenotech Laboratories Ltd. 2007-10-03 - Stake Purchase
Hyderabad, India
Terapia SA 2006-03-29 324M USD Add-on Acquisition
Cluj-Napoca, Romania · www.terapia.ro
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 324M (100%) - -
Total 2 $324M - -

By Geo

State/Country Buy Value Sell Value
India 1 - - -
Romania 1 324M - -
Domestic 1 (50%) - - -
Cross-border 1 (50%) 324M (100%) - -
Total 2 $324M - -

Deal Values

buy # Total
$100M to $1B 1 $324M
TOTAL $324M
Largest Terapia SA
$324M (2006-03-29)

M&A Connections

Deals
Acquired from
Investor(s)
50%
1 (50%)

 Subscribe to unlock this and 171,590
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 161K M&A Transactions
  • 167K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 59K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Ranbaxy Laboratories Ltd.

Life Science Companies , India Companies